Royal Philips has introduced BlueSeal Horizon, the world’s first helium-free 3.0T MRI platform, combining advanced artificial intelligence capabilities with sustainable magnet technology. The system was unveiled at RSNA 2025 in Chicago, representing what the company describes as a major scientific achievement in magnetic resonance imaging.
A comprehensive global survey commissioned by Philips has identified substantial trust disparities between healthcare professionals and patients regarding artificial intelligence implementation in medical care, with professionals showing significantly greater optimism about AI’s potential to improve patient outcomes.
Royal Philips has announced the successful first implantation of its Duo Venous Stent System following premarket approval from the U.S. Food and Drug Administration. The device is indicated for treating symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI).
Royal Philips, a leader in health technology, has launched a new cardiac care platform aimed at transforming diagnostic cardiology in Europe, the Middle East, and Africa. The Philips Cardiac Workstation utilises sophisticated algorithms to expedite the collection and processing of electrocardiograph (ECG) data, potentially streamlining care and helping to prioritise high-risk patients.
April 2024
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.